362 related articles for article (PubMed ID: 11425419)
1. Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib.
Rocha JL; Fernández-Alonso J
Lancet; 2001 Jun; 357(9272):1946-7. PubMed ID: 11425419
[TBL] [Abstract][Full Text] [Related]
2. [Tubulointerstitial nephritis associated with treatment with selective Cox-2 inhibitors, celecoxib and rofecoxib].
Ortiz M; Mon C; Fernández MJ; Sánchez R; Mampaso F; Alvarez Ude F
Nefrologia; 2005; 25(1):39-43. PubMed ID: 15789535
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous presentation of rofecoxib-induced acute hepatitis and acute interstitial nephritis.
Haider M; Gain E; Khadem G; Pilmore H; Yun K; Jayasinghe N; Walker R
Intern Med J; 2005 Jun; 35(6):370-2. PubMed ID: 15892770
[No Abstract] [Full Text] [Related]
4. Celecoxib-induced acute interstitial nephritis.
Henao J; Hisamuddin I; Nzerue CM; Vasandani G; Hewan-Lowe K
Am J Kidney Dis; 2002 Jun; 39(6):1313-7. PubMed ID: 12046048
[TBL] [Abstract][Full Text] [Related]
5. Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: case report and review of the literature.
Szalat A; Krasilnikov I; Bloch A; Meir K; Rubinger D; Mevorach D
Arthritis Rheum; 2004 Aug; 51(4):670-3. PubMed ID: 15334443
[No Abstract] [Full Text] [Related]
6. Adverse oral reactions associated with the COX-2 inhibitor rofecoxib.
Bagán JV; Thongprasom K; Scully C
Oral Dis; 2004 Nov; 10(6):401-3. PubMed ID: 15533219
[TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity of selective COX-2 inhibitors.
Woywodt A; Schwarz A; Mengel M; Haller H; Zeidler H; Köhler L
J Rheumatol; 2001 Sep; 28(9):2133-5. PubMed ID: 11550988
[TBL] [Abstract][Full Text] [Related]
8. [Therapy with rofecoxib. Decreasing risk by controlled COX-2 inhibitor administration].
MMW Fortschr Med; 2000 Nov; 142(48):64-5. PubMed ID: 11144940
[No Abstract] [Full Text] [Related]
9. Acute renal dysfunction associated with selective COX-2 inhibitor therapy.
Papaioannides D; Bouropoulos C; Sinapides D; Korantzopoulos P; Akritidis N
Int Urol Nephrol; 2001; 33(4):609-11. PubMed ID: 12452607
[TBL] [Abstract][Full Text] [Related]
10. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Weir MR; Sperling RS; Reicin A; Gertz BJ
Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
[TBL] [Abstract][Full Text] [Related]
11. [Acute and subacute renal failure].
Praxis (Bern 1994); 2008 Oct; 97(20):1057-64; quiz 1065-6. PubMed ID: 18850521
[No Abstract] [Full Text] [Related]
12. [Gastrointestinal damage induced by celecoxib and rofecoxib in rats].
Laudanno OM; Cesolari JA; Esnarriaga J; Rista L; Piombo G; Maglione C; Aramberry LJ; Sambrano JS; Godoy A; Rocaspana A
Acta Gastroenterol Latinoam; 2000; 30(1):27-33. PubMed ID: 10855352
[TBL] [Abstract][Full Text] [Related]
13. Metformin lactic acidosis, acute renal failure and rofecoxib.
Price G
Br J Anaesth; 2003 Dec; 91(6):909-10. PubMed ID: 14633764
[TBL] [Abstract][Full Text] [Related]
14. [Acute tubulointerstitial nephritis in HIV infection].
Möddel M; Pfammatter R; Varga Z; Keusch G
Praxis (Bern 1994); 2006 Jun; 95(23):949-51. PubMed ID: 16779906
[TBL] [Abstract][Full Text] [Related]
15. Intracranial hypertension induced by rofecoxib.
Jacob S; Rajabally YA
Headache; 2005 Jan; 45(1):75-6. PubMed ID: 15663617
[TBL] [Abstract][Full Text] [Related]
16. Acute renal failure after administration of a single dose of a highly selective COX-2 inhibitor.
Reinhold SW; Fischereder M; Riegger GA; Krämer BK
Clin Nephrol; 2003 Oct; 60(4):295-6. PubMed ID: 14579947
[No Abstract] [Full Text] [Related]
17. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
Galli G; Panzetta G
G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
[TBL] [Abstract][Full Text] [Related]
18. Acute interstitial nephritis and COX-2 inhibition.
Chow KM; Szeto CC; Li P; Lai FM
Hosp Med; 2003 Jul; 64(7):429. PubMed ID: 12886856
[No Abstract] [Full Text] [Related]
19. Are rofecoxib and celecoxib safer NSAIDS?
Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
[TBL] [Abstract][Full Text] [Related]
20. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.
Mamdani M; Juurlink DN; Lee DS; Rochon PA; Kopp A; Naglie G; Austin PC; Laupacis A; Stukel TA
Lancet; 2004 May; 363(9423):1751-6. PubMed ID: 15172772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
